The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis
- PMID: 8857998
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis
Abstract
This paper attempts to put together in the form of a flow sheet (Fig. 1) the several known alterations, both chemical and structural, of brain tissue in Alzheimer disease, which ultimately result in dementia. While most investigators in the field believe strongly that amyloid deposition is at the core of the disease, this writer finds that a more coherent, and thus more satisfying, schema can be based on the centrality of cytoskeletal abnormality. Not only do all four identified genes interact one way or another with the cytoskeleton, but abnormality of the latter leads to alterations of the Golgi apparatus with effects on protein processing, and on axoplasmic flow such that one can expect loss of synapses and subsequent loss of neurons with consequent disconnection and loss of neurotransmitters. Dementia is the result.
Comment in
-
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.J Neuropathol Exp Neurol. 1997 Feb;56(2):213. J Neuropathol Exp Neurol. 1997. PMID: 9034375 No abstract available.
-
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.J Neuropathol Exp Neurol. 1997 Feb;56(2):214-5. J Neuropathol Exp Neurol. 1997. PMID: 9034376 No abstract available.
-
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.J Neuropathol Exp Neurol. 1997 Feb;56(2):216. J Neuropathol Exp Neurol. 1997. PMID: 9034377 No abstract available.
-
The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.J Neuropathol Exp Neurol. 1997 Feb;56(2):217. J Neuropathol Exp Neurol. 1997. PMID: 9034378 No abstract available.
Similar articles
-
Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.Neurobiol Aging. 2005 May;26(5):607-13. doi: 10.1016/j.neurobiolaging.2004.06.010. Neurobiol Aging. 2005. PMID: 15708435
-
Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis.Eur J Neurosci. 2004 Aug;20(3):811-7. doi: 10.1111/j.1460-9568.2004.03534.x. Eur J Neurosci. 2004. PMID: 15255991
-
Caspases land on APP: one small step for apoptosis, one giant leap for amyloidosis?Nat Neurosci. 1999 Jul;2(7):585-6. doi: 10.1038/10133. Nat Neurosci. 1999. PMID: 10404170 No abstract available.
-
[Advances in molecular pathology of Alzheimer's disease].Rev Neurol. 2006 Mar 1-15;42(5):306-9. Rev Neurol. 2006. PMID: 16538595 Review. Spanish.
-
Alzheimer's disease: beta-Amyloid protein and tau.J Neurosci Res. 2002 Nov 1;70(3):392-401. doi: 10.1002/jnr.10355. J Neurosci Res. 2002. PMID: 12391602 Review.
Cited by
-
Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice.J Alzheimers Dis. 2016;52(3):1111-23. doi: 10.3233/JAD-151136. J Alzheimers Dis. 2016. PMID: 27060957 Free PMC article.
-
Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.Neuromolecular Med. 2002;1(1):1-31. doi: 10.1385/NMM:1:1:1. Neuromolecular Med. 2002. PMID: 12025813 Review.
-
The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.Curr Neuropharmacol. 2006 Apr;4(2):149-63. doi: 10.2174/157015906776359531. Curr Neuropharmacol. 2006. PMID: 18615129 Free PMC article.
-
Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease.Neurobiol Dis. 2014 Feb;62:31-43. doi: 10.1016/j.nbd.2013.09.001. Epub 2013 Sep 8. Neurobiol Dis. 2014. PMID: 24021662 Free PMC article.
-
Posttranslational modifications of α-tubulin in alzheimer disease.Transl Neurodegener. 2015 May 15;4:9. doi: 10.1186/s40035-015-0030-4. eCollection 2015. Transl Neurodegener. 2015. PMID: 26029362 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical